Companies Reporting Before The Bell
• Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.
Over the past 3 months, 4 analysts have published their opinion on Sprouts Farmers Market (NASDAQ:SFM) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
Pulled from Benzinga Pro data, Sprouts Farmers Market (NASDAQ:SFM) posted Q4 earnings of $36.23 million, an increase from Q3 of 43.28%. Sales dropped to $1.49 billion, a 1.13% decrease between quarters.
Sprouts Farmers Market (NASDAQ:SFM) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:02 PM.
Here's what investors need to know about the announcement.
Sprouts Farmers Market (NASDAQ:SFM) is set to give its latest quarterly earnings report on Thursday, 2022-02-24. Here's what investors need to know before the announcement.
Analysts estimate that Sprouts Farmers Market will report an earnings per share (EPS) of $0.30.